Nippon Suisan Kaisha Ltd.

10/14/2021 | Press release | Distributed by Public on 10/13/2021 22:00

Notice of passing eligibility examination as active pharmaceutical ingredient (API) producing facility by US Food and Drug Administration (FDA)